含有黄素原药和的酸在骨肉瘤治疗中具有双功能的作用
Mingjie Wang1, Chunfeng Xu1, Dong Xu2,3,4
1Academic Centre for Dentistry Amsterdam (ACTA), Department of Oral Cell Biology, Vrije Universiteit Amsterdam and University of Amsterdam, 1081 LA Amsterdam, The Netherlands.
Journal of functional biomaterials
|November 26, 2024
概括
这项研究引入了一种结合和在酸上的新生物材料,用于增强癌症治疗和骨再生. 这种新材料显示出协同作用的抗癌效应,并促进骨质生成,为骨癌治疗提供了潜力.
科学领域:
- 生物材料科学 生物材料科学
- 纳米技术纳米技术
- 癌症研究 癌症研究
背景情况:
- 酸用于癌症治疗,但骨再生仍然是一个挑战.
- 黄素表现出抗癌性质,并促进骨质生成.
- 开发多功能生物材料对于结合癌症治疗和骨修复至关重要.
研究的目的:
- 开发一种新的生物材料 (mcur-Se@BioCaP-Ads),在仿生酸盐 (BioCaP) 上结合 (SeO32-) 和黄素 (mcur).
- 评估新生物材料对骨髓瘤 (OS) 细胞的协同抗癌疗效.
- 评估生物材料在促进骨组织再生方面的潜力.
主要方法:
- 将SeO32-离子共同沉到BioCaP中以形成Se@BioCaP.
- 在Se@BioCaP表面上对修饰的黄素前药物 (mcur) 的吸附 (mcur-Se@BioCaP-Ads).
- 评估pH响应释放,OS细胞中的体外抗癌活性,以及MC3T3-E1前骨质细胞中的骨质生成潜力.
主要成果:
- Se@BioCaP表现出更高的含量和可调节的微/纳米结构.
- mcur-Se@BioCaP-Ads证明了Se和mcur的pH响应释放.
- 在OS细胞中观察到协同作用的抗癌作用,超过单剂疗效,可能通过ROS生产.
- 在骨质前细胞中发现性酸酶活性增加和结节的形成.
结论:
- 新的mcur-Se@BioCaP-Ads生物材料显示了对OS细胞有前途的协同抗癌活性.
- 该材料有效地促进骨质分化,表明骨组织再生的潜力.
- 这种多功能生物材料具有治疗骨髓瘤和增强骨修复的巨大潜力.
相关概念视频
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K


